Copyright Reports & Markets. All rights reserved.

Global and United States Diabetes Testing Program Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Diabetes Testing Program Revenue in Diabetes Testing Program Business (2017-2022) & (US$ Million) Introduction
    • 1.2 Global Diabetes Testing Program Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Diabetes Testing Program Market Size for the Year 2017-2028
      • 1.2.2 Global Diabetes Testing Program Market Size for the Year 2017-2028
    • 1.3 Diabetes Testing Program Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.3.1 The Market Share of United States Diabetes Testing Program in Global, 2017 VS 2022 VS 2028
      • 1.3.2 The Growth Rate of Diabetes Testing Program Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.4 Diabetes Testing Program Market Dynamics
      • 1.4.1 Diabetes Testing Program Industry Trends
      • 1.4.2 Diabetes Testing Program Market Drivers
      • 1.4.3 Diabetes Testing Program Market Challenges
      • 1.4.4 Diabetes Testing Program Market Restraints
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Diabetes Testing Program by Type

    • 2.1 Diabetes Testing Program Market Segment by Type
      • 2.1.1 Instruments
      • 2.1.2 Testing Kits
      • 2.1.3 Reagent
    • 2.2 Global Diabetes Testing Program Market Size by Type (2017, 2022 & 2028)
    • 2.3 Global Diabetes Testing Program Market Size by Type (2017-2028)
    • 2.4 United States Diabetes Testing Program Market Size by Type (2017, 2022 & 2028)
    • 2.5 United States Diabetes Testing Program Market Size by Type (2017-2028)

    3 Diabetes Testing Program by Application

    • 3.1 Diabetes Testing Program Market Segment by Application
      • 3.1.1 Hospitals
      • 3.1.2 Specialty Clinics
      • 3.1.3 Diagnostic Centers
      • 3.1.4 Home Care Settings
      • 3.1.5 Academic Research Institutes
    • 3.2 Global Diabetes Testing Program Market Size by Application (2017, 2022 & 2028)
    • 3.3 Global Diabetes Testing Program Market Size by Application (2017-2028)
    • 3.4 United States Diabetes Testing Program Market Size by Application (2017, 2022 & 2028)
    • 3.5 United States Diabetes Testing Program Market Size by Application (2017-2028)

    4 Global Diabetes Testing Program Competitor Landscape by Company

    • 4.1 Global Diabetes Testing Program Market Size by Company
      • 4.1.1 Top Global Diabetes Testing Program Companies Ranked by Revenue (2021)
      • 4.1.2 Global Diabetes Testing Program Revenue by Player (2017-2022)
    • 4.2 Global Diabetes Testing Program Concentration Ratio (CR)
      • 4.2.1 Diabetes Testing Program Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Companies of Diabetes Testing Program in 2021
      • 4.2.3 Global Diabetes Testing Program Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Diabetes Testing Program Headquarters, Revenue in Diabetes Testing Program Business (2017-2022) & (US$ Million) Type
      • 4.3.1 Global Diabetes Testing Program Headquarters and Area Served
      • 4.3.2 Global Diabetes Testing Program Companies Revenue in Diabetes Testing Program Business (2017-2022) & (US$ Million) Type
      • 4.3.3 Date of International Companies Enter into Diabetes Testing Program Market
    • 4.4 Companies Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Diabetes Testing Program Market Size by Company
      • 4.5.1 Top Diabetes Testing Program Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Diabetes Testing Program Revenue by Players (2020, 2021 & 2022)

    5 Global Diabetes Testing Program Market Size by Region

    • 5.1 Global Diabetes Testing Program Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Diabetes Testing Program Market Size by Region (2017-2028)
      • 5.2.1 Global Diabetes Testing Program Market Size by Region: 2017-2022
      • 5.2.2 Global Diabetes Testing Program Market Size by Region (2023-2028)

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Diabetes Testing Program Market Size YoY Growth 2017-2028
      • 6.1.2 North America Diabetes Testing Program Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Diabetes Testing Program Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Diabetes Testing Program Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Diabetes Testing Program Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Diabetes Testing Program Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Diabetes Testing Program Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Diabetes Testing Program Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
      • 6.4.6 Colombia
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Diabetes Testing Program Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Diabetes Testing Program Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 InSphero AG
      • 7.1.1 InSphero AG Company Details
      • 7.1.2 InSphero AG Business Overview
      • 7.1.3 InSphero AG Diabetes Testing Program Introduction
      • 7.1.4 InSphero AG Revenue in Diabetes Testing Program Business (2017-2022)
      • 7.1.5 InSphero AG Recent Development
    • 7.2 Abbott Laboratories
      • 7.2.1 Abbott Laboratories Company Details
      • 7.2.2 Abbott Laboratories Business Overview
      • 7.2.3 Abbott Laboratories Diabetes Testing Program Introduction
      • 7.2.4 Abbott Laboratories Revenue in Diabetes Testing Program Business (2017-2022)
      • 7.2.5 Abbott Laboratories Recent Development
    • 7.3 American Laboratory Products Company (ALPCO)
      • 7.3.1 American Laboratory Products Company (ALPCO) Company Details
      • 7.3.2 American Laboratory Products Company (ALPCO) Business Overview
      • 7.3.3 American Laboratory Products Company (ALPCO) Diabetes Testing Program Introduction
      • 7.3.4 American Laboratory Products Company (ALPCO) Revenue in Diabetes Testing Program Business (2017-2022)
      • 7.3.5 American Laboratory Products Company (ALPCO) Recent Development
    • 7.4 Beckmann Coulter Inc.
      • 7.4.1 Beckmann Coulter Inc. Company Details
      • 7.4.2 Beckmann Coulter Inc. Business Overview
      • 7.4.3 Beckmann Coulter Inc. Diabetes Testing Program Introduction
      • 7.4.4 Beckmann Coulter Inc. Revenue in Diabetes Testing Program Business (2017-2022)
      • 7.4.5 Beckmann Coulter Inc. Recent Development
    • 7.5 Bio-Rad Laboratories Inc.
      • 7.5.1 Bio-Rad Laboratories Inc. Company Details
      • 7.5.2 Bio-Rad Laboratories Inc. Business Overview
      • 7.5.3 Bio-Rad Laboratories Inc. Diabetes Testing Program Introduction
      • 7.5.4 Bio-Rad Laboratories Inc. Revenue in Diabetes Testing Program Business (2017-2022)
      • 7.5.5 Bio-Rad Laboratories Inc. Recent Development
    • 7.6 Ortho Clinical Diagnostics Inc.
      • 7.6.1 Ortho Clinical Diagnostics Inc. Company Details
      • 7.6.2 Ortho Clinical Diagnostics Inc. Business Overview
      • 7.6.3 Ortho Clinical Diagnostics Inc. Diabetes Testing Program Introduction
      • 7.6.4 Ortho Clinical Diagnostics Inc. Revenue in Diabetes Testing Program Business (2017-2022)
      • 7.6.5 Ortho Clinical Diagnostics Inc. Recent Development
    • 7.7 F. Hoffmann-la Roche Ltd
      • 7.7.1 F. Hoffmann-la Roche Ltd Company Details
      • 7.7.2 F. Hoffmann-la Roche Ltd Business Overview
      • 7.7.3 F. Hoffmann-la Roche Ltd Diabetes Testing Program Introduction
      • 7.7.4 F. Hoffmann-la Roche Ltd Revenue in Diabetes Testing Program Business (2017-2022)
      • 7.7.5 F. Hoffmann-la Roche Ltd Recent Development
    • 7.8 Siemens AG
      • 7.8.1 Siemens AG Company Details
      • 7.8.2 Siemens AG Business Overview
      • 7.8.3 Siemens AG Diabetes Testing Program Introduction
      • 7.8.4 Siemens AG Revenue in Diabetes Testing Program Business (2017-2022)
      • 7.8.5 Siemens AG Recent Development
    • 7.9 PTS Diagnostics
      • 7.9.1 PTS Diagnostics Company Details
      • 7.9.2 PTS Diagnostics Business Overview
      • 7.9.3 PTS Diagnostics Diabetes Testing Program Introduction
      • 7.9.4 PTS Diagnostics Revenue in Diabetes Testing Program Business (2017-2022)
      • 7.9.5 PTS Diagnostics Recent Development

    8 Research Findings and Conclusion

      9 Appendix

      • 9.1 Research Methodology
        • 9.1.1 Methodology/Research Approach
        • 9.1.2 Data Source
      • 9.2 Author Details

      Summary:

      A program for detecting diabetes, generally including fasting plasma glucose test, oral glucose tolerance test, etc.
      Market Analysis and Insights: Global and United States Diabetes Testing Program Market
      This report focuses on global and United States Diabetes Testing Program market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Diabetes Testing Program market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Instruments accounting for % of the Diabetes Testing Program global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Diabetes Testing Program market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
      Global Diabetes Testing Program Scope and Market Size
      Diabetes Testing Program market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Diabetes Testing Program market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Diabetes Testing Program market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Diabetes Testing Program market is segmented into
      Instruments
      Testing Kits
      Reagent
      Segment by Application, the Diabetes Testing Program market is segmented into
      Hospitals
      Specialty Clinics
      Diagnostic Centers
      Home Care Settings
      Academic Research Institutes
      Regional and Country-level Analysis
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Diabetes Testing Program Market Share Analysis
      Diabetes Testing Program market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Diabetes Testing Program business, the date to enter into the Diabetes Testing Program market, Revenue in Diabetes Testing Program Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
      The major vendors covered:
      InSphero AG
      Abbott Laboratories
      American Laboratory Products Company (ALPCO)
      Beckmann Coulter Inc.
      Bio-Rad Laboratories Inc.
      Ortho Clinical Diagnostics Inc.
      F. Hoffmann-la Roche Ltd
      Siemens AG
      PTS Diagnostics
      Buy now